Sophie Vantyghem

Burden of Illness for Metastatic Melanoma in Canada, 2011–2013

D. Scott Ernst, Teresa M. Petrella, Anthony M. Joshua et al. · Current Oncology · 2016 · 19 citations · Full text

B Cell Aplasia Is the Most Powerful Predictive Marker for Poor Humoral Response after BNT162b2 mRNA SARS-CoV-2 Vaccination in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

Maxime Jullien, Amandine Le Bourgeois, Marianne Coste‐Burel et al. · Transplantation and Cellular Therapy · 2022 · 14 citations · Full text

Autologous stem-cell collection following VTD or VRD induction therapy in multiple myeloma: a single-center experience

Vanille Laurent, Clémentine Fronteau, Chloé Antier et al. · Bone Marrow Transplantation · 2020 · 13 citations

Hematological Malignancy, Cell Therapy, Oncology +10

Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life study

Sophie Vantyghem, Pierre Péterlin, Sylvain Thépot et al. · Haematologica · 2020 · 11 citations · Full text

Mixed-phenotype Acute Leukemia, Genetics, Pathology +18